imaging-platform_link-card)Garvan-Institute.jpg

Imaging

data-science_platform_Garvan-Institute.jpg

Data Science

Providing expertise and support for data intensive medical research. 

CT&E_link-card_Garvan-Institute.jpg

Clinical Translation and Engagement

The CT&E platform provides advanced expertise translating Garvan’s research to achieve clinical, social and economic impact. 

genomics-platform_link-card_Garvan-Institute.jpg

Genomics

Biologics-link-card_Garvan-Institute.jpg

Biologics

development-link-card_Garvan-Institute.jpg

Development

Associate Professors Clare Stirzaker and David Croucher

Clare_Stirzaker_and_David_Croucher_Garvan_Institute.jpg

Cancer Council NSW grants will support innovative approaches to monitoring breast cancer recurrence and improving treatment effectiveness for high-risk neuroblastoma.

Breast cancer blood test and childhood cancer projects given the green light

Ira_Deveson_Garvan_Institute

A major new Garvan-led research project will develop advanced DNA analysis methods to provide a more detailed picture of the human genome, improving access to the benefits of genetic medicine for diverse populations.

Research to unlock life-changing benefits from advanced DNA analysis

Maté Biro Garvan Institute.jpg

Associate Professor Maté Biro brings specialised expertise in how immune cells interact with tumours to the Institute’s Cancer Ecosystems Program.


Garvan appoints leading expert in cancer-immune interactions

Ira_Deveson_Garvan_Institute-2.jpg

Dr Ira Deveson will receive the Ruth Stephens Gani Medal at the 2025 Science at the Shine Dome event, in recognition of his contributions to clinical genomics and bioinformatics. 

Australian Academy of Science honours Garvan genomics researcher

Associate Professors Owen Siggs and Jodie Ingles are leading the Genomics of Rare Disease Registry

Jodie_Ingles_and_Owen_Siggs_Garvan_Institute-2.jpg

Sydney researchers are recruiting for a study aimed at improving diagnosis, treatment and support for an estimated two million people who live with rare genetic diseases in Australia alone.

Recruiting now: study to uncover genetic cause of rare diseases

Dr-Shona-Ritchie_Garvan-Institute.jpg

Dr Shona Ritchie has received Cancer Institute NSW funding to explore how a cholesterol-regulating medication could make existing chemotherapies more effective against pancreatic cancer.

Garvan researcher to investigate cholesterol-lowering drug for pancreatic cancer treatment

Sophie Hespe
and Associate Professor Jodie Ingles

Jodie_Sophie_Garvan-Institute.jpg

Garvan researchers update guidelines on which genes should – and which should not – be included in genetic testing for patients with hypertrophic cardiomyopathy.

Researchers refine genetic test panel for inherited cardiomyopathy

Professor Paul Timpson, Dr Cecilia Chambers and Dr David Herrmann

Professor-Paul-Timpson_Dr-Cecilia-Chambers_Dr-David-Herrmann_Garvan-Institute.jpg

Scientists identify a molecule that fuels pancreatic cancer spread to the liver, opening new avenues for treatment.

A metabolism switch that could help stop the spread of pancreatic cancer

Dr Brooke Pereira with her Excellency the Honourable Ms Sam Mostyn AC at the Fulbright Gala

Brooke-Pereira-Fulbright-Gala-Garvan-Institute.jpg

Garvan’s Dr Brooke Pereira has been awarded the prestigious Fulbright Scholarship to embark on an exchange to the US, where she will investigate new therapy targets for pancreatic cancer.

Dr Brooke Pereira awarded Fulbright Scholarship

Clockwise from top left: Dr Kylie James, Dr Curtis Cai, Dr Ruebena Dawes, Dr Etienne Masle-Farquhar and Dr Drew Neavin

Kylie-James-Curtis-Cai-Ruebena-Dawes-Etienne-Masle-Farquhar-Drew-Neavin-v3.jpg

National Health and Medical Research Council backs five Garvan scientists to pursue solutions for complex diseases affecting millions of Australians.

Next wave of medical research backed by national grants

Latest news 

platforms_Garvan-Institute.jpg

Garvan Institute has a breadth of research platforms offering research expertise, coupled with services.